Every earnings call for PIDILITIND — management tone, guidance, KPIs and promise tracking, quarter by quarter.
PIDILITIND · 5 transcripts · Chemicals · latest Q4 FY26FY26 Consolidated Revenue ₹14,553 cr (+11% YoY); EBITDA Margin 23.4%. Stand-alone revenue grew by 15.3% in value terms, underpinned by 15.3% underlying volume growth (UVG).
Read full transcript & analysisStandalone Revenue ₹3,425 cr (+11% YoY); Standalone EBITDA Margin 24.5 percent. Standalone revenue of INR 3,425 crores, 11% nominal growth with 9.3% UVG.
Read full transcript & analysisStandalone Revenue (Q2) ₹3,272 cr (+10% YoY). Standalone revenue of INR 3,272 crores with UVG of 10.3% and value growth of 10.4%.
Read full transcript & analysisStandalone Revenue ₹3,425 cr (+11% YoY); Standalone EBITDA Margin 24.5 percent. Standalone revenue of INR 3,425 crores, 11% nominal growth with 9.3% UVG.
Read full transcript & analysisConsolidated Revenue ₹3,130 cr (+10% YoY); Standalone EBITDA Margin 20.6%. Q4 FY25 standalone revenue grew 10.2%, with UVG of 9.8%.
Read full transcript & analysis